Get the Stockscreener App
0.7135
11.28%
0.0723
After Hours:
.70
-0.0135
-1.89%
Genenta Science Spa Adr stock is traded at $0.7135, with a volume of 69,715.
It is up +11.28% in the last 24 hours and down -18.92% over the past month.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
See More
Previous Close:
$0.6412
Open:
$0.6648
24h Volume:
69,715
Relative Volume:
0.07
Market Cap:
$16.83M
Revenue:
-
Net Income/Loss:
$-7.33M
P/E Ratio:
-1.9216
EPS:
-0.3713
Net Cash Flow:
$-8.02M
1W Performance:
+0.85%
1M Performance:
-18.92%
6M Performance:
-77.70%
1Y Performance:
-81.36%
1-Day Range:
$0.66
$0.72
1-Week Range:
$0.625
$0.72
52-Week Range:
$0.59
$10.00
Genenta Science Spa Adr Stock (GNTA) Company Profile
Name
Genenta Science Spa Adr
Sector
Industry
Phone
-
Address
-
Compare GNTA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNTA
Genenta Science Spa Adr
|
0.7135 | 15.13M | 0 | -7.33M | -8.02M | -0.3713 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-29-23 | Resumed | ROTH MKM | Buy |
| Jul-25-22 | Initiated | H.C. Wainwright | Buy |
| Jan-13-22 | Initiated | Maxim Group | Buy |
Genenta Science Spa Adr Stock (GNTA) Latest News
Genenta Science receives Nasdaq notice on minimum bid price compliance By Investing.com - Investing.com India
Genenta Science receives Nasdaq notice on minimum bid price compliance - Investing.com
Genenta Science Warned by Nasdaq Over Minimum Bid Price Compliance - TipRanks
GNTA Stock Price, Quote & Chart | GENENTA SCIENCE SPAADR (NASDAQ:GNTA) - ChartMill
What's going on in today's pre-market session - chartmill.com
Genenta Moves to Acquire Control of Italian Space-Defense Supplier Sòphia High Tech - TipRanks
Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs - GlobeNewswire Inc.
Genenta Science Cancels Late-March Vote on Rebrand to Saentra Forge - The Globe and Mail
Genenta Science SPA (GNTA) Shifting from Biotech to Defense Business - Finviz
11 Best Italian Stocks to Buy in 2026 - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Reviva Pharmaceuticals Holdings (RVPH) and Prenetics Group (PRE) - The Globe and Mail
Genenta Science Piv A Strategic Shift from Biotech to Defense - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Aprea Therapeutics (APRE) - The Globe and Mail
Genenta Science stock soars on strategic pivot to defense sector By Investing.com - Investing.com Australia
Genenta Science stock soars on strategic pivot to defense sector - Investing.com
Genenta to Rebrand as Saentra Forge and Pivot into Italian National-Security Industrial Consolidator - TipRanks
Analysts Offer Insights on Healthcare Companies: Xenon (XENE) and BioLife Solutions (BLFS) - The Globe and Mail
Genenta Science (NASDAQ:GNTA) Trading Up 0.7% – Here’s What Happened - Defense World
Operating cash flow per share of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView — Track All Markets
Return on equity % of Genenta Science SpA Sponsored ADR – LSX:A3C9EK - TradingView
Healthy Upside Potential: Genenta Science SpA ADR (GNTA) - Setenews
Genenta Science stock soars after update on glioblastoma treatment study By Investing.com - Investing.com Australia
Genenta Science stock soars after update on glioblastoma treatment study - Investing.com
Genenta Science (NASDAQ:GNTA) Shares Down 3.4% – Should You Sell? - Defense World
Candlestick signals on Genenta Science S.p.A. Depositary Receipt stock todayProduct Launch & Short-Term Trading Opportunity Alerts - newser.com
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Altimmune (ALT), Dogwood Therapeutics (DWTX) - The Globe and Mail
Genenta Science Expands Board and Corporate Purpose Following Shareholders’ Meeting - MSN
Weiss Ratings Reiterates Sell (D-) Rating for Genenta Science (NASDAQ:GNTA) - MarketBeat
Genenta Science (NASDAQ:GNTA) Stock Price Down 4.7%What's Next? - MarketBeat
Genenta Science Appoints New Board Member and Confirms CEO - MSN
Genenta Science Secures $15 Million in Registered Direct Offering - The Globe and Mail
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket - inkl
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.71% - Investing.com UK
United States shares higher at close of trade; Dow Jones Industrial Average up 0.71% - Investing.com India
Leadership Change at Genenta Science SpA: Dr. Galimi Appointed Acting CMO - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.71% - Investing.com
Genenta Science stock plunges after $15 million ADS offering - Investing.com
Genenta Science stock plunges after $15 million ADS offering By Investing.com - Investing.com South Africa
Genenta Science appoints Dr. Francesco Galimi to board and approves 2024 financials By Investing.com - Investing.com South Africa
Genenta Science appoints Dr. Francesco Galimi to board and approves 2024 financials - Investing.com Philippines
Genenta Science Spa Adr Stock (GNTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):